Urofollitropin
尿促卵泡素
Report date: 2026/05/13 20:02:10
Base Information
Drug NameUrofollitropin
Drug Alias Name +[7]
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved Indications
Approved Indications in China
Original Approved Country/Territory
Original Approved Date1986/09/18
Country/Territory
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesMerck Serono
China Registration ClassN/A
Develop Information
Active CompaniesFerring BvSerono Singapore Pte Ltd. Beijing Office
Inactive CompaniesSeronoFerring GmbhFerring Arzneimittel Gmbh +[5]
Active Indications
Inactive Indications